NCT02414347View on ClinicalTrials.gov

F 18 T807 Tau PET Imaging of Alzheimer's Disease

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Alzheimer Disease
Interventions
DRUG

F 18 T807

Participants will receive a single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807. For those who cannot tolerate the full exam, participants will receive single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Tammie L. S. Benzinger, MD, PhD

OTHER